ALGN

Align Technology Inc. (ALGN) | Rumor.io

Align Technology

ALGN

Attention (50-day avg)0%

Attention rank (50-day avg)#2,803

Bullish sentiment (50-day avg)86%

Price to earnings ratio25.5

Market capitalization10.3B

Earnings per share5.75

Dividend yield (TTM)—

Revenue (annual)4B

Net income (annual)410.4M

Social

What share of all stock conversation is about ALGN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% +0	0% 0	0% 0

Jul 29

Align Technology reported Q2 2026 results with record revenue of $1.056B, up 4.3% YoY, driven by record Clear Aligner volumes.
The company expects Q3 2026 worldwide revenues of $1,000M to $1,020M and targets 2026 worldwide revenue growth of 3% to 4%.
Align Technology added three new independent directors and launched a strategic review with a top consulting firm, also increasing its buyback to $400M-$500M after Elliott engagement.

Generated by AI

Sentiment

Of the messages about ALGN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	86.67% -13.33	90% +30	69.8% +4.34
Bearish	0%	13.33% +13.33	10% -30	30.2% -4.34

Bullish· Mar 9

The asset's capabilities have been expanded with the rollout of AI diagnostics, potentially increasing its value.
The asset's market capitalization has been lifted, indicating a positive change in investor perception.
The asset's capabilities are being compared favorably to those of a major bank, suggesting its potential for growth.

Bearish· Aug 1

$ALGN's patent expiration has led to cheaper plastic alternatives, making it harder for the company to match traditional orthodontics results at the top end.
The company's margins are being compressed by a competitor, AngelAlign ($6699.hk), which is offering a good product at a lower price.
$ALGN's growth is slowing due to macro headwinds, and the company's valuation has been re-rated, leading to a significant decline in share price.

Generated by AI

Topics

Of the messages about ALGN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	0%	50%	34.06%
Technical Analysis	—	100%	50%	14.25%
Earnings	—	0%	0%	28.88%
Controversies	—	0%	0%	0.94%
Analysts	—	0%	0%	18.94%
Macro	—	0%	0%	2.94%

Earnings· Oct 29

Align Technology reported Q3 earnings with revenue of $995.7M, beating estimates of $976.3M, and EPS of $2.61, beating estimates of $2.41.
The company guided Q4 revenue to $1.025B-$1.045B, in line with estimates, and expects adjusted operating margin to be slightly above 22.5% for FY25.
The stock price surged over 15% after the earnings release, with investors reacting positively to the company's solid Q3 results and upgraded volume outlook.

Analysts· Feb 2

Goldman Sachs upgraded Align Technology ($ALGN) to neutral from sell and raised its price target to $307.
Several analysts, including Baird, Piper Sandler, and Stifel Nicolaus, raised their price targets for Align Technology ($ALGN) and maintained their "buy" or "outperform" ratings.
Analysts at Goldman Sachs, Baird, Piper Sandler, and Stifel Nicolaus raised their price targets for Align Technology ($ALGN) following the company's solid quarterly results.

Announcements· Jul 31

Align Technology's dental aligner demand is being compared to traditional braces, raising concerns about its market performance.
HSBC has adjusted its price target for Align Technology to $140 from $180.
The company's dental aligner demand is under scrutiny, with some questioning its growth prospects compared to traditional orthodontic treatments.

Technical Analysis· Jul 31

Align Technology, Inc. (ALGN) has reported a weaker-than-expected earnings performance, with revenue missing analysts' estimates and a cut in its 2025 forecast.
The stock has dropped significantly, with a 31% pre-market decline, and is currently testing the March 2020 low.
Historical patterns suggest that the stock may continue to experience weakness, but has repeatedly rebounded 50-100% from its bottom in the past, making it a potential buying opportunity.

Generated by AI

Community

Of the messages about ALGN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	70%	31.82%	56%	26.17%
Newcomers	30%	68.18%	44%	73.83%

Regulars· Nov 25

The company's Invisalign System has achieved commercial availability in the Philippines, with a new feature for mandibular advancement.
Align Technology's shares are trading higher after the commercial availability announcement, with some users attributing the move to a potential buyout.
The new Invisalign System with mandibular advancement features occlusal blocks for Class II skeletal and dental correction, offering an innovative treatment option for kids and teenage patients.

Newcomers· Jan 15

New investors are waiting for increased trading volume on NASDAQ to indicate a potential buying opportunity for ALGN.
The focus is on revenue scaling for RIME, the company behind ALGN, and the potential for growth.
Newcomers are highlighting the SaaS economics forming clearly for Algorhythm Holdings, Inc. (RIME), which could impact ALGN's future performance.

Generated by AI

News

Align Technology Inc. stock underperforms Monday when compared to competitors

1d agomarketwatch.com

Align Technology Inc. stock underperforms Thursday when compared to competitors

5d agoMarketWatch

Align Technology Inc. stock underperforms Wednesday when compared to competitors

6d agoMarketWatch

Also Discussed

Investors talking about ALGN also mention

#	Name	Attention
1	Dentsply Sirona Inc.XRAY	0%new
2	SDC - SmileDirectClub, Inc.	——
3	PDCO - Patterson Companies, Inc.	——
4	Henry Schein, Inc.HSIC	0%0
5	ABMD - Abiomed, Inc.	——
6	Envista Holdings Corp.NVST	0%0
7	AxoGen IncAXGN	0%new
8	Viomi Technology Co Ltd ADRVIOT	0%new
9	Atlassian Corporation Class A Common StockTEAM	0%+0
10	Bruker CorpBRKR	0%+0

Align Technology Inc.

Healthcare
Medical Instruments & Supplies

Align Technology Inc. is a medical device company focused on digital orthodontics and restorative dentistry. The company develops and markets the Invisalign clear aligner system, Vivera retainers, and a range of intraoral scanning and digital treatment-planning tools used by dental professionals. Its iTero scanners and related services support precise imaging, workflow efficiency, and chairside communication in orthodontic and general dentistry practices. Align Technology also offers exocad CAD/CAM software, extending its presence across dental design and fabrication workflows. The company serves dentists, orthodontists, and dental laboratories in markets around the world, with products designed to support treatment planning, patient monitoring, and restorative procedures. Align Technology plays a central role in the shift from traditional braces and analog dental processes to connected, software-enabled oral healthcare solutions.

Website

Location

410 North Scottsdale Road

Tempe, AZ, 85288

United States

Social

What share of all stock conversation is about ALGN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% +0	0% 0	0% 0

Jul 29

Align Technology reported Q2 2026 results with record revenue of $1.056B, up 4.3% YoY, driven by record Clear Aligner volumes.
The company expects Q3 2026 worldwide revenues of $1,000M to $1,020M and targets 2026 worldwide revenue growth of 3% to 4%.
Align Technology added three new independent directors and launched a strategic review with a top consulting firm, also increasing its buyback to $400M-$500M after Elliott engagement.

Generated by AI

Sentiment

Of the messages about ALGN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	86.67% -13.33	90% +30	69.8% +4.34
Bearish	0%	13.33% +13.33	10% -30	30.2% -4.34

Bullish· Mar 9

The asset's capabilities have been expanded with the rollout of AI diagnostics, potentially increasing its value.
The asset's market capitalization has been lifted, indicating a positive change in investor perception.
The asset's capabilities are being compared favorably to those of a major bank, suggesting its potential for growth.

Bearish· Aug 1

$ALGN's patent expiration has led to cheaper plastic alternatives, making it harder for the company to match traditional orthodontics results at the top end.
The company's margins are being compressed by a competitor, AngelAlign ($6699.hk), which is offering a good product at a lower price.
$ALGN's growth is slowing due to macro headwinds, and the company's valuation has been re-rated, leading to a significant decline in share price.

Generated by AI

Topics

Of the messages about ALGN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	0%	50%	34.06%
Technical Analysis	—	100%	50%	14.25%
Earnings	—	0%	0%	28.88%
Controversies	—	0%	0%	0.94%
Analysts	—	0%	0%	18.94%
Macro	—	0%	0%	2.94%

Earnings· Oct 29

Align Technology reported Q3 earnings with revenue of $995.7M, beating estimates of $976.3M, and EPS of $2.61, beating estimates of $2.41.
The company guided Q4 revenue to $1.025B-$1.045B, in line with estimates, and expects adjusted operating margin to be slightly above 22.5% for FY25.
The stock price surged over 15% after the earnings release, with investors reacting positively to the company's solid Q3 results and upgraded volume outlook.

Analysts· Feb 2

Goldman Sachs upgraded Align Technology ($ALGN) to neutral from sell and raised its price target to $307.
Several analysts, including Baird, Piper Sandler, and Stifel Nicolaus, raised their price targets for Align Technology ($ALGN) and maintained their "buy" or "outperform" ratings.
Analysts at Goldman Sachs, Baird, Piper Sandler, and Stifel Nicolaus raised their price targets for Align Technology ($ALGN) following the company's solid quarterly results.

Announcements· Jul 31

Align Technology's dental aligner demand is being compared to traditional braces, raising concerns about its market performance.
HSBC has adjusted its price target for Align Technology to $140 from $180.
The company's dental aligner demand is under scrutiny, with some questioning its growth prospects compared to traditional orthodontic treatments.

Technical Analysis· Jul 31

Align Technology, Inc. (ALGN) has reported a weaker-than-expected earnings performance, with revenue missing analysts' estimates and a cut in its 2025 forecast.
The stock has dropped significantly, with a 31% pre-market decline, and is currently testing the March 2020 low.
Historical patterns suggest that the stock may continue to experience weakness, but has repeatedly rebounded 50-100% from its bottom in the past, making it a potential buying opportunity.

Generated by AI

Community

Of the messages about ALGN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	70%	31.82%	56%	26.17%
Newcomers	30%	68.18%	44%	73.83%

Regulars· Nov 25

The company's Invisalign System has achieved commercial availability in the Philippines, with a new feature for mandibular advancement.
Align Technology's shares are trading higher after the commercial availability announcement, with some users attributing the move to a potential buyout.
The new Invisalign System with mandibular advancement features occlusal blocks for Class II skeletal and dental correction, offering an innovative treatment option for kids and teenage patients.

Newcomers· Jan 15

New investors are waiting for increased trading volume on NASDAQ to indicate a potential buying opportunity for ALGN.
The focus is on revenue scaling for RIME, the company behind ALGN, and the potential for growth.
Newcomers are highlighting the SaaS economics forming clearly for Algorhythm Holdings, Inc. (RIME), which could impact ALGN's future performance.

Generated by AI

Align Technology

Social

Jul 29

Bullish· Mar 9

Bearish· Aug 1

Earnings· Oct 29

Analysts· Feb 2

Announcements· Jul 31

Technical Analysis· Jul 31

Regulars· Nov 25

Newcomers· Jan 15

Align Technology Inc. stock underperforms Monday when compared to competitors

Align Technology Inc. stock underperforms Thursday when compared to competitors

Align Technology Inc. stock underperforms Wednesday when compared to competitors

Align Technology Inc. stock outperforms competitors on strong trading day

Align Technology Inc. stock underperforms Friday when compared to competitors

Align Technology Stock: Is ALGN Underperforming the Healthcare Sector?

Also Discussed

Align Technology Inc.

Company Information

Location

Align Technology Inc. stock underperforms Monday when compared to competitors

Align Technology Inc. stock underperforms Thursday when compared to competitors

Align Technology Inc. stock underperforms Wednesday when compared to competitors

Align Technology Inc. stock outperforms competitors on strong trading day

Align Technology Inc. stock underperforms Friday when compared to competitors

Align Technology Stock: Is ALGN Underperforming the Healthcare Sector?

Also Discussed

Social

Jul 29

Bullish· Mar 9

Bearish· Aug 1

Earnings· Oct 29

Analysts· Feb 2

Announcements· Jul 31

Technical Analysis· Jul 31

Regulars· Nov 25

Newcomers· Jan 15